ES2052378T3 - Metodo para predisponer a los mamiferos a una reparacion acelerada de los tejidos. - Google Patents
Metodo para predisponer a los mamiferos a una reparacion acelerada de los tejidos.Info
- Publication number
- ES2052378T3 ES2052378T3 ES91908101T ES91908101T ES2052378T3 ES 2052378 T3 ES2052378 T3 ES 2052378T3 ES 91908101 T ES91908101 T ES 91908101T ES 91908101 T ES91908101 T ES 91908101T ES 2052378 T3 ES2052378 T3 ES 2052378T3
- Authority
- ES
- Spain
- Prior art keywords
- mammals
- tissues
- preparing
- repair
- expedited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Laser Surgery Devices (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
SE SUMINISTRA UN METODO DE PREDISPOSICION DE UN MAMIFERO A LA REPARACION ACELERADA DE LOS TEJIDOS. ESTE METODO COMPRENDE LA ADMINISTRACION SISTEMATICA AL MAMIFERO, PREVIA A LA EXPOSICION A DAÑOS EN LOS TEJIDOS, DE UNA CANTIDAD EFICAZ DE TGF-(BETA). PREFERIBLEMENTE, SE ADMINISTRA EL TGF-(BETA) NO MAS DE 24 HORAS ANTES DE LA EXPOSICION A DAÑOS EN LOS TEJIDOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/504,495 US5108989A (en) | 1990-04-04 | 1990-04-04 | Method of predisposing mammals to accelerated tissue repair |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2052378T3 true ES2052378T3 (es) | 1994-07-01 |
Family
ID=24006516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91908101T Expired - Lifetime ES2052378T3 (es) | 1990-04-04 | 1991-03-20 | Metodo para predisponer a los mamiferos a una reparacion acelerada de los tejidos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5108989A (es) |
EP (1) | EP0527787B1 (es) |
JP (1) | JPH05506030A (es) |
AT (1) | ATE102043T1 (es) |
CA (1) | CA2078547A1 (es) |
DE (1) | DE69101316T2 (es) |
DK (1) | DK0527787T3 (es) |
ES (1) | ES2052378T3 (es) |
WO (1) | WO1991015222A2 (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824297A (en) * | 1990-06-25 | 1998-10-20 | Oncogene Science, Inc. | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
US6506729B1 (en) * | 1991-03-11 | 2003-01-14 | Curis, Inc. | Methods and compositions for the treatment and prevention of Parkinson's disease |
CA2363965C (en) * | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
US6495513B1 (en) | 1991-03-11 | 2002-12-17 | Curis, Inc. | Morphogen-enhanced survival and repair of neural cells |
US6211146B1 (en) * | 1991-03-11 | 2001-04-03 | Curis, Inc. | 60A protein-induced morphogenesis |
US6723698B2 (en) * | 1991-03-11 | 2004-04-20 | Curis, Inc. | Methods and compositions for the treatment of motor neuron injury and neuropathy |
US5849686A (en) * | 1991-03-11 | 1998-12-15 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
US5739107A (en) * | 1991-03-11 | 1998-04-14 | Creative Biomolecules, Inc. | Morphogen treatment of gastrointestinal ulcers |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US6022853A (en) * | 1991-08-30 | 2000-02-08 | Creative Biomolecules, Inc. | Morphogen-enriched dietary composition |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6204240B1 (en) | 1991-11-22 | 2001-03-20 | Genentech, Inc. | TGF-β1 to improve neural outcome |
AU3243393A (en) * | 1991-12-10 | 1993-07-19 | Rush - Presbyterian - St. Luke's Medical Center | Methods and compositions for reducing multi-drug resistance |
US5681812A (en) * | 1991-12-10 | 1997-10-28 | Rush Presbyterian-St. Luke's Medical Center | Methods and compositions for reducing multidrug resistance |
US5767079A (en) * | 1992-07-08 | 1998-06-16 | Celtrix Pharmaceuticals, Inc. | Method of treating ophthalmic disorders using TGF -β |
US5817625A (en) * | 1992-09-21 | 1998-10-06 | Oncogene Science, Inc. | Methods of prevention of oral mucositis with transforming growth factor beta |
US6395494B1 (en) * | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
DE69435137D1 (de) * | 1993-05-13 | 2008-10-16 | Poniard Pharmaceuticals Inc | Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind |
EP0670732A1 (en) * | 1993-09-29 | 1995-09-13 | Alcon Laboratories, Inc. | Compositions containing growth factors and antimetabolites |
US5449671A (en) * | 1993-09-29 | 1995-09-12 | Alcon Laboratories, Inc. | Use of TGF-β3, to prevent or retard fistula closure following glaucoma filtration surgery |
CA2149657A1 (en) * | 1993-09-29 | 1995-04-06 | Billie M. York | Compositions containing growth factors and antiplastic agents |
US5411940A (en) * | 1993-09-29 | 1995-05-02 | Alcon Laboratories, Inc. | Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
AU2275395A (en) * | 1994-03-31 | 1995-10-23 | Biomedical Explorations, Llc | Therapeutic homeopathic dilutions of growth factors and methods of their use |
CA2223595C (en) | 1995-06-07 | 2008-08-05 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
US6040431A (en) * | 1995-06-07 | 2000-03-21 | Stryker Corporation | Single chain analogs of the TGF-β superfamily (morphons) |
US6214796B1 (en) | 1996-03-22 | 2001-04-10 | The General Hospital Corporation | Administration of polypeptide growth factors following central nervous system ischemia or trauma |
WO1998024466A1 (en) * | 1996-12-05 | 1998-06-11 | Alcon Laboratories, Inc. | THE USE OF INHIBITORS OF TGF-β'S FUNCTIONS TO AMELIORATE OCULAR PATHOLOGY |
US6117911A (en) | 1997-04-11 | 2000-09-12 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
US6179840B1 (en) | 1999-07-23 | 2001-01-30 | Ethicon, Inc. | Graft fixation device and method |
US20020095157A1 (en) * | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
US6599323B2 (en) * | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
US6852330B2 (en) | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
CA2365376C (en) * | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
EP1256316A1 (en) | 2001-05-07 | 2002-11-13 | Move2Health B.V. | Portable device comprising an acceleration sensor and method of generating instructions or advice |
US20040078090A1 (en) * | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
US7824701B2 (en) * | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
US8226715B2 (en) * | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
US10583220B2 (en) * | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
US7901461B2 (en) * | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
US11395865B2 (en) * | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
US8657881B2 (en) * | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
US8221780B2 (en) * | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
US7373820B1 (en) | 2004-11-23 | 2008-05-20 | James Terry L | Accelerometer for data collection and communication |
US8376984B2 (en) * | 2005-07-14 | 2013-02-19 | Terry L. James | Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin |
US20080306762A1 (en) * | 2007-06-08 | 2008-12-11 | James Terry L | System and Method for Managing Absenteeism in an Employee Environment |
US20090048493A1 (en) * | 2007-08-17 | 2009-02-19 | James Terry L | Health and Entertainment Device for Collecting, Converting, Displaying and Communicating Data |
EP3103463B1 (en) * | 2007-09-19 | 2020-01-01 | Pluristem Ltd. | Adherent cells from adipose or placenta tissues and use thereof in therapy |
US7676332B2 (en) * | 2007-12-27 | 2010-03-09 | Kersh Risk Management, Inc. | System and method for processing raw activity energy expenditure data |
US20090204422A1 (en) * | 2008-02-12 | 2009-08-13 | James Terry L | System and Method for Remotely Updating a Health Station |
US20100016742A1 (en) * | 2008-07-19 | 2010-01-21 | James Terry L | System and Method for Monitoring, Measuring, and Addressing Stress |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61346B1 (en) * | 1988-11-02 | 1994-11-02 | Genentech Inc | A permeable material to fit around the teeth or gums of a mammal |
WO1991000103A1 (en) * | 1989-06-29 | 1991-01-10 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1 |
-
1990
- 1990-04-04 US US07/504,495 patent/US5108989A/en not_active Expired - Lifetime
-
1991
- 1991-03-20 AT AT91908101T patent/ATE102043T1/de not_active IP Right Cessation
- 1991-03-20 WO PCT/US1991/001861 patent/WO1991015222A2/en active IP Right Grant
- 1991-03-20 DK DK91908101.8T patent/DK0527787T3/da active
- 1991-03-20 DE DE69101316T patent/DE69101316T2/de not_active Expired - Lifetime
- 1991-03-20 CA CA002078547A patent/CA2078547A1/en not_active Abandoned
- 1991-03-20 EP EP91908101A patent/EP0527787B1/en not_active Expired - Lifetime
- 1991-03-20 ES ES91908101T patent/ES2052378T3/es not_active Expired - Lifetime
- 1991-03-20 JP JP91507583A patent/JPH05506030A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0527787A1 (en) | 1993-02-24 |
WO1991015222A3 (en) | 1991-11-14 |
CA2078547A1 (en) | 1991-10-05 |
DK0527787T3 (da) | 1994-08-22 |
WO1991015222A2 (en) | 1991-10-17 |
ATE102043T1 (de) | 1994-03-15 |
DE69101316D1 (de) | 1994-04-07 |
DE69101316T2 (de) | 1994-08-11 |
JPH05506030A (ja) | 1993-09-02 |
EP0527787B1 (en) | 1994-03-02 |
US5108989A (en) | 1992-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2052378T3 (es) | Metodo para predisponer a los mamiferos a una reparacion acelerada de los tejidos. | |
ES2098229T3 (es) | Compuestos de pirazolopiridina y procedimientos para su preparacion. | |
ES2034893B1 (es) | Procedimiento para la obtencion de nuevos pregna-1,4-diene-3,20-dione-16-17-acetal-21 esteres. | |
ES2100151T3 (es) | Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos. | |
ES2074219T3 (es) | 1,4,7,10-tetraazaciclododecano-butiltrioles, procedimiento para su preparacion y agentes farmaceuticos que los contienen. | |
ES2060362T3 (es) | Metodo para aumentar la fertilidad en los machos. | |
DK0506853T3 (da) | Anvendelse af GABA-B selektive agonister som antitussive midler | |
ES2133289T3 (es) | Aumento en los niveles de glutation con glutamina. | |
ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
AR014964A1 (es) | Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones | |
SE8004125L (sv) | Kolestrolderivat | |
MX6160E (es) | Procedimiento para la preparacion de n-(2-fenil 2-hidroxietil)-1,1-dimetil-3-(4-fenil sustituidas)propilaminas | |
ATE158506T1 (de) | Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine | |
ES2095068T3 (es) | Peroxicarbonatos polimericos y procedimiento para prepararlos. | |
ES2106031T3 (es) | Una composicion comprendiendo un factor de crecimiento, su metodo de obtencion y uso. | |
IS4367A (is) | CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín | |
ES2138100T3 (es) | Procedimiento para la preparacion de 1,5-benzotiazepinas por ciclizacion de esteres aminicos. | |
ES2077473T3 (es) | Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
DK532679A (da) | Fremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo (4,1,0)hepten-(2)-on-(5). | |
SE8104072L (sv) | Metafenylendiaminer och sett for framstellning derav | |
DE3460834D1 (en) | Derivatives of bicyclo(4.2.0)octatriene-1,3,5, their preparation and their therapeutical application | |
ES506313A0 (es) | Un procedimiento para la preparacion de derivados de benzo (4,5 pinano 2,3c) pirrol. | |
ES2071793T3 (es) | Nuevos derivados de la pirrolidona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
MX14537A (es) | Procedimiento para la preparacion de hidroxialquil-1 nitroimidazoles y agentes de hidroxialquilacion. | |
MX10256A (es) | Procedimiento para preparar nuevas 3-fenil-7h-tiazolo(3, 2-b) (1, 2, 4) triazin-7-onas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 527787 Country of ref document: ES |